For the Inventor, By the Inventor

Enter assignee name

Zhejiang, China

Zhejiang Hisun Pharmaceutical Co., Ltd.

USPTO Granted Patents = 62

CIPO Patents = 4

EPO Patents = 42

Trademarks = 4

Forward Citations = 55

Loading Chart...

Loading Chart...

204 inventors (with patents filed for the assignee):

Hua Bai (37 out of 40 patents)

Lei Chen (9 out of 15 patents)

Zhiqing Yang (9 out of 9 patents)

4. Xuyang Zhao (9 out of 9 patents)

5. Dongliang Guan (7 out of 7 patents)

6. Fuli Zhang (7 out of 11 patents)

7. Xiaohe Zheng (7 out of 7 patents)

8. Jian Chai (7 out of 7 patents)

9. Xiaoyu Liu (7 out of 7 patents)

10. Qifeng Zhu (6 out of 6 patents)

11. Yuncai Zhang (6 out of 6 patents)

12. Xiaojie Xu (6 out of 6 patents)

13. Linghui Zheng (5 out of 5 patents)

14. Liang Zhang (4 out of 46 patents)

15. Taishan Hu (4 out of 22 patents)

Core Competencies:

Macrolide Derivatives

Pyrimidine Derivatives

Piperazine Amide Derivatives

Indazole Amine Derivatives

Tetrahydroisoquinoline Derivatives

DoxA Protein Mutants

Acrylic Acid Derivatives

Recombinant Microorganisms

Photodynamic Therapy

Antiparasitic Drugs

Crystal Forms

Intermediate Compounds

62 patents: Sort by Forward Citations

1. 12410191 - Macrolide derivatives, preparation method and application thereof (2025-09-09),

2. 12358898 - Pyrimidine derivative, method for preparing same and use thereof in medicine (2025-07-15),

3. 12234222 - Piperazine amide derivative, preparation method therefor, and use thereof in medicine (2025-02-25),

4. 11897863 - Indazole amine derivative, preparation method therefor and medical use thereof (2024-02-13),

5. 11827625 - Pyrimidine derivative, method for preparing same and use thereof in medicine (2023-11-28),

6. 11622939 - HS-25 tablet and preparation method therefor (2023-04-11),

7. 11421255 - Method for enzymatic preparation of fludarabine phosphate (2022-08-23),

8. 11384097 - Tetrahydroisoquinoline derivative, preparation method therefor and use thereof (2022-07-12),

9. 11371026 - DoxA protein mutant, and coding gene and applications thereof (2022-06-28),

10. 11142531 - Cyano substituted heteroarylpyrimidinone derivative, preparation method and use thereof (2021-10-12),

11. 11001572 - Pyrimidine derivative, method for preparing same and use thereof in medicine (2021-05-11),

12. 10844415 - Spinosad heterologous expression strain and construction method thereof and use (2020-11-24),

13. 10669302 - Crystal form of fludarabine phosphate, preparation method therefor, and application thereof (2020-06-02),

14. 10654836 - Pyrimidine derivative, method for preparing same and use thereof in medicine (2020-05-19),

15. 10548933 - Method for preparing broccoli protein peptide mixture (2020-02-04),

Zhejiang Hisun Pharmaceutical Co., Ltd. is a leading pharmaceutical company based in Zhejiang, China. With a focus on research, production, and sale of pharmaceutical products, Hisun Pharma has become one of the top manufacturers in the industry. Their products range from chemical raw materials to finished medicines, covering various therapeutic areas such as cardiovascular, anti-infection, and oncology. Committed to quality and innovation, Hisun Pharma strives to provide safe and effective healthcare solutions globally.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Jan 6 2026

62 Patents

#13 in Zhejiang

#480 in China

#11,480 in the World

Zhejiang, China

Zhejiang Hisun Pharmaceutical Co., Ltd.

Forward Citations = 55

204 inventors:

Hua Bai (37 out of 40 patents)

Lei Chen (9 out of 15 patents)

Zhiqing Yang (9 out of 9 patents)

4. Xuyang Zhao (9 out of 9 patents)

5. Dongliang Guan (7 out of 7 patents)

Please report any incorrect information to support@idiyas.com

Loading…